Figure 4.

MiR-944 overexpression inhibited progression of non-small cell lung cancer (NSCLC) in vitro. (A) The transfection efficiency of miR-NC, miR-944 mimics, and miR-944 inhibitor was demonstrated using qRT-PCR in A549 and H1299 cells. ^**P < 0.01 vs. miR-NC; (B) MTT assay were performed after transfected with miR-944 mimics or miR-NC in A549 and H1299 cells. ^**P < 0.01 vs. miR-NC; (C and D) The effects of miR-944 overexpression on migration and invasion rates of A549 and H1299 cells were assessed. ^**P < 0.01 vs. miR-NC; (E) Western blot was performed to evaluate the protein levels of Bax and Bcl-2 in A549 and H1299 cells. ^**P < 0.01 vs. miR-NC.